A diagnostic test for cochlear synaptopathy in humans
The CochSyn-test aims to diagnose the first signs of permanent hearing damage with a 10-15 min clinical hearing- screening test. The test quantifies cochlear synaptopathy, i.e. damage to the cochlear auditory-nerve fiber synapses...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EarDiTech
Precision Hearing Diagnostics and Augmented-hearing Technolo...
2M€
Cerrado
READIHEAR
Rehabilitation and Diagnosis of Hearing Loss based on Electr...
2M€
Cerrado
BFU2012-39544-C02-01
DIFERENCIACION DE LA DISFUNCION DE CELULAS CILIADAS INTERNAS...
105K€
Cerrado
Tinnitus Platform
Commercialization of novel Diagnostic Platform with Synaptic...
71K€
Cerrado
EDHI
A Novel Toolkit for the Early Diagnosis of Hearing Impairmen...
181K€
Cerrado
RobSpear
Robust Speech Encoding in Impaired Hearing
1M€
Cerrado
Información proyecto CochSyn
Duración del proyecto: 21 meses
Fecha Inicio: 2020-05-11
Fecha Fin: 2022-02-28
Líder del proyecto
UNIVERSITEIT GENT
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The CochSyn-test aims to diagnose the first signs of permanent hearing damage with a 10-15 min clinical hearing- screening test. The test quantifies cochlear synaptopathy, i.e. damage to the cochlear auditory-nerve fiber synapses due to ageing, noise-exposure or ototoxicity, with a non-invasive auditory test. Because synaptopathy is associated with reduced speech intelligibility and occurs before the audiogram shows signs of hearing damage, our test is more sensitive than the audiogram (present clinical standard) and can quantify a widespread form of sensorineural hearing loss. The CochSyn test makes early-diagnosis and early-intervention possible, which the WHO determined as cost- effective in reducing the financial burden associated with untreated hearing loss.
In this PoC project, we plan to fine-tune the CochSyn-test and build a normative dataset of test outcomes for a diverse population of people at risk for synaptopathy. This dataset is necessary to (i) determine the application area of the test and enable a precise diagnostic interpretation, (ii) convince ENT doctors about adopting the test and companies to invest in it, and (iii), convince health agencies and policy makers that synaptopathy is an important health risk, given its impact on degrading speech intelligibility in noisy listening environments.